CD19 and myeloid sarcoma: In order to evaluate the relationship between the frequency of CD19+CD24hiCD38hi cells and CD19+PD-L1hi cells with disease activity of MS, the frequency and the absolute number were measured in total CD19+ B cells in MS-relapse and MS-remission and HC.